Tirzepatide: tested on its own
147 studies: no other medicine in its arm. Page 1 of 2. Open to participants first (79), then studies with results posted, then the rest; newest registration first within each.
- Tirzepatide and Organ-specific Biological AgingEnrolling by invitationNCT07906041Phase 2Report a problem
- Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With ObesityNot yet recruitingNCT07893457Phase 4Report a problem
- PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility StudyRecruitingNCT07874828Phase 2Report a problem
- Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative StudyRecruitingNCT07866183Not applicableReport a problem
- Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep ApnoeaNot yet recruitingNCT07846865Phase 2/3Report a problem
- Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialNot yet recruitingNCT07829198Phase 3Report a problem
- Randomized Controlled Trial of Tirzepatide for Methamphetamine Use DisorderRecruitingNCT07825857Phase 2Report a problem
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)RecruitingNCT07817875Phase 3Report a problem
- Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial CancerNot yet recruitingNCT07812636Early Phase 1Report a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesityRecruitingNCT07803744Phase 1Report a problem
- Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving LorlatinibRecruitingNCT07782359Phase 1Report a problem
- Impact of GLP-1 Receptor Agonist Therapy on Alcohol PharmacokineticsNot yet recruitingNCT07758231Phase 1Report a problem
- GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPDNot yet recruitingNCT07747805Phase 2Report a problem
- Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityNot yet recruitingNCT07738276Phase 3Report a problem
- Tirzepatide for Treatment of CCCARecruitingNCT07734870Phase 2Report a problem
- Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized TrialRecruitingNCT07734792Phase 2/3Report a problem
- Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic PatientsNot yet recruitingNCT07728318Not applicableReport a problem
- Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese PatientsNot yet recruitingNCT07715929Phase 4Report a problem
- Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIVEnrolling by invitationNCT07707778Phase 4Report a problem
- Effect of Tirzepatide on Diabetic Peripheral Sensorimotor NeuropathyNot yet recruitingNCT07706088Phase 4Report a problem
- Tirzepatide in the Treatment of Cannabis Use DisorderNot yet recruitingNCT07671248Phase 3Report a problem
- Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEFNot yet recruitingNCT07630454Phase 4Report a problem
- Tirzepatide in the Treatment of Endometrial CancerNot yet recruitingNCT07605247Phase 2Report a problem
- Multi-Site Trial of Tirzepatide for Smoking CessationRecruitingNCT07602699Phase 2Report a problem
- Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.RecruitingNCT07588438Phase 4Report a problem
- Tirzepatide Titration to Reduce Side Effects in Individuals With ObesityRecruitingNCT07574723Not applicableReport a problem
- Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionRecruitingNCT07573163Phase 2Report a problem
- Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)RecruitingNCT07559500Phase 1Report a problem
- Incretin Therapies in Obesity-related HFpEFRecruitingNCT07554638Phase 4Report a problem
- Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)RecruitingNCT07481747Phase 3Report a problem
- Trial of Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07468552Phase 2Report a problem
- Tirzepatide (Spartina) in Obese Kidney Transplant RecipientsRecruitingNCT07423247Phase 4Report a problem
- Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and ReinitiationRecruitingNCT07387796Not applicableReport a problem
- Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial FibrillationNot yet recruitingNCT07382024Not applicableReport a problem
- Tirzepatide and Muscle Outcomes in ObesityRecruitingNCT07373834Not applicableReport a problem
- A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young AdultsRecruitingNCT07364175Not applicableReport a problem
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07349641Phase 2Report a problem
- Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)Not yet recruitingNCT07292519Phase 2Report a problem
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarRecruitingNCT07284511Phase 2/3Report a problem
- Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07265752Phase 2Report a problem
- Tirzepatide's Role in Postmenopausal HR+ Breast Cancer SurvivorsRecruitingNCT07257484Phase 4Report a problem
- A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)RecruitingNCT07247084Phase 4Report a problem
- Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With ObesityRecruitingNCT07228741Phase 2Report a problem
- Tirzepatide to Slow Biological AgingRecruitingNCT07220473Phase 2Report a problem
- The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With ObesityRecruitingNCT07218445Phase 4Report a problem
- Tirzepatide in Idiopathic Intracranial Hypertension TrialRecruitingNCT07191873Phase 4Report a problem
- Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney FailureNot yet recruitingNCT07176663Not applicableReport a problem
- GLP-1R Actions on Muscle and the SkeletonRecruitingNCT07154719Phase 4Report a problem
- Tirzepatide Use in People With Obesity and Type 1 DiabetesRecruitingNCT07096908Phase 4Report a problem
- Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal TumorsRecruitingNCT07095517Phase 1Report a problem
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial CancerNot yet recruitingNCT07078838Phase 2Report a problem
- Tirzepatide in Obesity-Driven Endometrial CancerRecruitingNCT07065552Early Phase 1Report a problem
- Tirzepatide in MetALDRecruitingNCT07046819Phase 2Report a problem
- Tirzepatide for Alcohol Use DisorderRecruitingNCT06994338Phase 2Report a problem
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's DiseaseRecruitingNCT06976853Phase 2Report a problem
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use DisorderRecruitingNCT06939088Phase 2Report a problem
- Effect of Tirzepatide on Markers of MASLD in Patients With ObesityRecruitingNCT06934642Early Phase 1Report a problem
- Tirzepatide in PWS, HO and GNSORecruitingNCT06901245Phase 4Report a problem
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RecruitingNCT06857942Phase 4Report a problem
- Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating DisorderRecruitingNCT06847399Phase 2Report a problem
- Acute Metabolic Effects of Tirzepatide in Type 1 DiabetesRecruitingNCT06820281Phase 2Report a problem
- Effects of Tirzepatide on Muscle and Vascular Health in Obese Older AdultsRecruitingNCT06811324Phase 2Report a problem
- TIRzepatide for the Treatment of Obesity in Patients With Atrial FibrillationRecruitingNCT06802081Phase 2Report a problem
- Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility StudyRecruitingNCT06759701Early Phase 1Report a problem
- Study of Tirzepatide for Recovery and Alcohol Use ManagementRecruitingNCT06727331Phase 2Report a problem
- 2024 Tirzepatide-Bariatric SurgeryRecruitingNCT06721507Phase 4Report a problem
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use DisorderRecruitingNCT06651177Phase 2Report a problem
- GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 DiabetesRecruitingNCT06630585Phase 3Report a problem
- The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery DiseaseRecruitingNCT06606821Phase 4Report a problem
- Glucagon-Like Peptide-1 Receptor Agonist in ADPKDRecruitingNCT06582875Phase 2Report a problem
- Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerRecruitingNCT06518837Phase 2Report a problem
- Tirzepatide Weight Loss for MRD+ Early Breast CancerRecruitingNCT06517212Phase 2Report a problem
- A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)RecruitingNCT06439277Phase 3Report a problem
- Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis SuppurativaNot yet recruitingNCT06301256Not applicableReport a problem
- Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or ObesityNot yet recruitingNCT06180616Phase 2Report a problem
- Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/ObesityRecruitingNCT05912621Phase 2Report a problem
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCTRecruitingNCT05708859Phase 4Report a problem
- Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1RecruitingNCT05659368Phase 2Report a problem
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 DiabetesRecruitingNCT05553093Phase 4Report a problem
- A Study of Tirzepatide (LY3298176) in Healthy Lactating FemalesCompletedNCT05978713Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)CompletedNCT05963022Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related ComorbiditiesCompletedNCT05822830Phase 3Results postedReport a problem
- A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection DevicesCompletedNCT05810597Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)CompletedNCT05706506Phase 4Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Pediatric Participants With ObesityCompletedNCT05696847Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesCompletedNCT05691712Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)CompletedNCT05564039Phase 4Results postedReport a problem
- A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesActive, not recruitingNCT05433584Phase 4Results postedReport a problem
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep ApneaCompletedNCT05412004Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)CompletedNCT05024032Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT TrialCompletedNCT04847557Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Obesity DiseaseCompletedNCT04844918Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight LossCompletedNCT04660643Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss ProgramCompletedNCT04657016Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightCompletedNCT04657003Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without MetforminCompletedNCT04537923Phase 3Results postedReport a problem
- A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using TirzepatideCompletedNCT04407234Phase 1Results postedReport a problem
- Study of Tirzepatide in Healthy ParticipantsCompletedNCT04311424Phase 1Results postedReport a problem
- A Study of Tirzepatide in Overweight and Very Overweight ParticipantsCompletedNCT04311411Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT04255433Phase 3Results postedReport a problem